Abu Dhabi, Pfizer ink deal to boost clinical trials ecosystem – ArabianBusiness

Abu Dhabi, Pfizer ink deal to boost clinical trials ecosystem – ArabianBusiness

The Department of Health – Abu Dhabi (DoH) has announced a new collaboration with Pfizer to develop national competencies and clinical research capacity in the emirate.

The mutual agreement will focus on developing clinical trials conduct and enhancing research efforts and medical processes in the Abu Dhabi, a statement said.

It added that Pfizer will support DoH in establishing a training curriculum that’s specialised in advancing the early phase of clinical trials and drug development programmes.

The collaboration reflects the emirate’s continuous efforts to upgrade the digital health system and foster innovation in healthcare.

Through this collaboration, Pfizer seeks to train up to 150 clinical researchers who will also have an opportunity of research mentorship support by Pfizer research partner within two years supporting DoH aim of reaching 500 qualified clinical researchers by 2025 through various collaborations and initiatives.

Dr Jamal Mohammed Al Kaabi, Under-Secretary of DoH, said: “DoH is committed to positioning Abu Dhabi as an incubator for innovation in the field of life sciences and as a leading healthcare destination in the world. We do this by providing a legislative environment that attracts and motivates research and